
Vijay Shankar
Examiner (ID: 12272, Phone: (571)272-7682 , Office: P/2697 )
| Most Active Art Unit | 2624 |
| Art Unit(s) | 2614, 2624, 2673, 2777, 2607, 2629, 2622, 2697, 2778, 2605, 2775, 2787, 2743 |
| Total Applications | 2665 |
| Issued Applications | 2187 |
| Pending Applications | 287 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11023734
[patent_doc_number] => 20160220689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/917915
[patent_app_country] => US
[patent_app_date] => 2014-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30961
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917915
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917915 | MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES | Sep 9, 2014 | Abandoned |
Array
(
[id] => 11277072
[patent_doc_number] => 09493546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Fibronectin based scaffold domain proteins that bind to myostatin'
[patent_app_type] => utility
[patent_app_number] => 14/481641
[patent_app_country] => US
[patent_app_date] => 2014-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 56963
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481641
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/481641 | Fibronectin based scaffold domain proteins that bind to myostatin | Sep 8, 2014 | Issued |
Array
(
[id] => 16681721
[patent_doc_number] => 10941187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => GLP-1, exendin-4, peptide analogs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/470528
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 45
[patent_no_of_words] => 23996
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/470528 | GLP-1, exendin-4, peptide analogs and uses thereof | Aug 26, 2014 | Issued |
Array
(
[id] => 10997412
[patent_doc_number] => 20160194358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'LINEAR PEPTIDE ANTIBIOTCS'
[patent_app_type] => utility
[patent_app_number] => 14/911823
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 104341
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911823
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911823 | LINEAR PEPTIDE ANTIBIOTCS | Aug 13, 2014 | Abandoned |
Array
(
[id] => 16058455
[patent_doc_number] => 10688151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Peptides having specificity for the lungs
[patent_app_type] => utility
[patent_app_number] => 14/911197
[patent_app_country] => US
[patent_app_date] => 2014-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 10306
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911197
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911197 | Peptides having specificity for the lungs | Aug 5, 2014 | Issued |
Array
(
[id] => 10938912
[patent_doc_number] => 20140341934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'PROCESS FOR EXTRACTING MATERIALS FROM BIOLOGICAL MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 14/451845
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2781
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451845
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/451845 | Process for extracting materials from biological material | Aug 4, 2014 | Issued |
Array
(
[id] => 10820468
[patent_doc_number] => 20160166632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS'
[patent_app_type] => utility
[patent_app_number] => 14/905179
[patent_app_country] => US
[patent_app_date] => 2014-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22660
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905179
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/905179 | PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS | Jul 16, 2014 | Abandoned |
Array
(
[id] => 10920375
[patent_doc_number] => 20140323395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 14/330495
[patent_app_country] => US
[patent_app_date] => 2014-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 60863
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14330495
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/330495 | Methods for Treating HCV | Jul 13, 2014 | Abandoned |
Array
(
[id] => 10967051
[patent_doc_number] => 20140370082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/324146
[patent_app_country] => US
[patent_app_date] => 2014-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25238
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324146
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324146 | CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS | Jul 3, 2014 | Abandoned |
Array
(
[id] => 9799537
[patent_doc_number] => 20150011481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 14/320843
[patent_app_country] => US
[patent_app_date] => 2014-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8429
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14320843
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/320843 | Methods for Treating HCV | Jun 30, 2014 | Abandoned |
Array
(
[id] => 15227615
[patent_doc_number] => 10501518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Alpha-/beta-polypeptide analogs of parathyroid hormone (PTH) and method of using same
[patent_app_type] => utility
[patent_app_number] => 14/312012
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 41
[patent_no_of_words] => 13542
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312012
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312012 | Alpha-/beta-polypeptide analogs of parathyroid hormone (PTH) and method of using same | Jun 22, 2014 | Issued |
Array
(
[id] => 10975340
[patent_doc_number] => 20140378375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'ALPHA/BETA-POLYPEPTIDE ANALOGS OF GLUCAGON-LIKE PEPTIDE 1'
[patent_app_type] => utility
[patent_app_number] => 14/312081
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11583
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312081
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312081 | Alpha/beta-polypeptide analogs of glucagon-like peptide-1 | Jun 22, 2014 | Issued |
Array
(
[id] => 10776239
[patent_doc_number] => 20160122394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/897999
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 47726
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897999
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897999 | FC receptor (FcRn) binding peptides and uses thereof | Jun 17, 2014 | Issued |
Array
(
[id] => 10912785
[patent_doc_number] => 20140315801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'METHODS OF TREATMENT OF CELL PROLIFERATIVE AND/OR OPHTHALMIC DISEASES, DISORDERS AND CONDITIONS USING INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/308408
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 160365
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/308408 | METHODS OF TREATMENT OF CELL PROLIFERATIVE AND/OR OPHTHALMIC DISEASES, DISORDERS AND CONDITIONS USING INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY | Jun 17, 2014 | Abandoned |
Array
(
[id] => 10782921
[patent_doc_number] => 20160129077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma'
[patent_app_type] => utility
[patent_app_number] => 14/907263
[patent_app_country] => US
[patent_app_date] => 2014-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7107
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907263
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/907263 | Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma | Jun 12, 2014 | Abandoned |
Array
(
[id] => 10776233
[patent_doc_number] => 20160122389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'PEPTIDES WITH ANTAGONISTIC ACTIVITIES AGAINST NATURAL CXCR4'
[patent_app_type] => utility
[patent_app_number] => 14/896249
[patent_app_country] => US
[patent_app_date] => 2014-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9865
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896249
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896249 | Peptides with antagonistic activities against natural CXCR4 | Jun 11, 2014 | Issued |
Array
(
[id] => 14360683
[patent_doc_number] => 10301629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
[patent_app_type] => utility
[patent_app_number] => 14/897450
[patent_app_country] => US
[patent_app_date] => 2014-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 39069
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897450 | Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides | Jun 10, 2014 | Issued |
Array
(
[id] => 11053371
[patent_doc_number] => 20160250333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'SUBCUTANEOUS INJECTION PREPARATION FOR INDUCING BOVINE SUPEROVULATION'
[patent_app_type] => utility
[patent_app_number] => 14/907165
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4463
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907165
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/907165 | Subcutaneous injection product for cattle for inducing superovulation | May 22, 2014 | Issued |
Array
(
[id] => 9720934
[patent_doc_number] => 20140256634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Treatments for Gastrointestinal Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/286145
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16070
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14286145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/286145 | Treatments for Gastrointestinal Disorders | May 22, 2014 | Abandoned |
Array
(
[id] => 10729616
[patent_doc_number] => 20160075765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'MODIFIED COLLAGEN MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/890037
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14616
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/890037 | MODIFIED COLLAGEN MOLECULES | May 8, 2014 | Abandoned |